These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3063437)

  • 21. Fendiline and calmidazolium enhance the release of endothelium-derived relaxant factor and of prostacyclin from cultured endothelial cells.
    Busse R; Lückhoff A; Winter I; Mülsch A; Pohl U
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):79-84. PubMed ID: 3285226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Torsade de pointes due to prenylamine controlled by lignocaine.
    Tamari I; Rabinowitz B; Neufeld HN
    Eur Heart J; 1982 Aug; 3(4):389-92. PubMed ID: 7128627
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of the calcium antagonist fendiline on tone and motility of the guinea pig gut smooth muscle and the cAMP and cGMP concentrations of the isolated terminal ileum.
    Sprügel W; Mitznegg P; Heim F
    Arzneimittelforschung; 1977; 27(3):571-4. PubMed ID: 194604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.
    Spedding M; Berg C
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):69-75. PubMed ID: 6083458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?
    Surawicz B
    J Am Coll Cardiol; 1989 Jul; 14(1):172-84. PubMed ID: 2661626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two calcium antagonists, verapamil and fendiline, in an experimental model of myocardial ischaemia mimicking classical angina on effort.
    Csik V; Szekeres L; Udvary E
    Br J Pharmacol; 1983 May; 79(1):37-43. PubMed ID: 6871551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of prenylamine on cardiac membrane currents and contractility.
    Haas HG; Kern R; Benninger C; Einwächter HM
    J Pharmacol Exp Ther; 1975 Mar; 192(3):688-701. PubMed ID: 1079048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM; Cysouw KJ; Verdouw PD
    Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of prenylamine on transmembrane action potentials as related to the change in external potassium concentrations in guinea pig papillary muscle.
    Ban T; Kojima M; Sada H; Oshita S
    J Cardiovasc Pharmacol; 1982; 4(4):601-8. PubMed ID: 6181334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets.
    Lückhoff A; Bohnert M; Busse R
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):96-101. PubMed ID: 2030746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple coronary vasospasm: a cause of repeated myocardial infarction and symptomatic 'torsade de pointes' (atypical ventricular tachycardia). A case presentation and review.
    Przybojewski JZ
    S Afr Med J; 1983 Jan; 63(4):103-12. PubMed ID: 6336853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fendiline-Induced Ca2+ movement in A10 smooth muscle cells.
    Lo YK; Cheng JS; Wang JL; Lee KC; Chou KJ; Chang HT; Tang KY; Jan CR
    Chin J Physiol; 2001 Mar; 44(1):19-24. PubMed ID: 11403516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fendiline inhibits L-type calcium channels in guinea-pig ventricular myocytes: a whole-cell patch-clamp study.
    Tripathi O; Schreibmayer W; Tritthart HA
    Br J Pharmacol; 1993 Apr; 108(4):865-9. PubMed ID: 8485628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenylamine-induced contracture of frog skeletal muscle.
    Kirsten EB; Lustig KC
    Br J Pharmacol; 1977 May; 60(1):97-105. PubMed ID: 301764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of prenylamine syncope (torsades de pointes)].
    Oda E; Takeda K; Ohno T; Nagai T; Shibuya T; Aizawa Y; Arai Y; Ozawa T; Shibata A
    Kokyu To Junkan; 1985 Mar; 33(3):453-8. PubMed ID: 4012076
    [No Abstract]   [Full Text] [Related]  

  • 38. Calcium antagonists affect calmodulin-dependent contractility of a skinned smooth muscle.
    Metzger H; Stern HO; Pfitzer G; Rüegg JC
    Arzneimittelforschung; 1982; 32(11):1425-7. PubMed ID: 6891247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.
    Shah RR; Stonier PD
    Ther Adv Drug Saf; 2018 Aug; 9(8):475-493. PubMed ID: 30364900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.